OSSIO
John Clark Byrnes is a seasoned sales professional with extensive experience in the medical device and healthcare industries. Currently serving as Regional Sales Manager at OSSIO since January 2023, Byrnes previously held positions as an Independent Distributor at JP Med Solutions LLC and Area Vice President of Sales at WR Specialists. With a strong background in sales management, Byrnes managed a team of 18 Medical Device representatives as Director of Sales for Bioventus from 2012 to 2020 and held the same title at Smith & Nephew from 2003 to 2012. Earlier experience includes roles as an Orthopedic Specialty Representative at Merck and a Financial Advisor at Morgan Stanley. Byrnes holds a Bachelor's degree in Kinesiology and Exercise Science from the University of North Carolina at Greensboro, earned between 1990 and 1995.
This person is not in any offices
OSSIO
OSSIO is an orthopedic fixation company committed to transforming the orthopedic experience for patients, physicians, and payors. Their vision is to provide the first credible replacement to metal implants in the $10B+ orthopedic fixation market (screws, pins, plates) with an Intelligent Bone Regeneration Technology. OSSIOfiber represents abreakthrough material platform for orthopedic and podiatric surgeons who seek a more biologically friendly way to restore patient stability and mobility with nothing permanent left behind.Founded in 2014, OSSIO began as the culmination of years of biomechanical research and a vision for the possibility of better bone healing. The technological basis of OSSIOfiber™ was developed and would lay the groundwork for ushering in a new breakthrough category of non-permanent fixation, “Bio-Integratives” hardware that has both desired strength AND bio-friendliness. Hardware that has the mechanical strength for easy insertion and secure fixation, while enabling the body to regrow bone, incorporating and replacing the implant (without the adverse inflammation and weakness often seen in “bio-resorbables and other “bio-composites”), has remained elusive to the industry until now.